IMBRUVICA Trademark

Trademark Overview

On Wednesday, July 10, 2013, a trademark application was filed for IMBRUVICA with the United States Patent and Trademark Office. The USPTO has given the IMBRUVICA trademark a serial number of 86007097. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, July 11, 2024. This trademark is owned by Pharmacyclics, Inc.. The IMBRUVICA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer
imbruvica

General Information

Serial Number86007097
Word MarkIMBRUVICA
Filing DateWednesday, July 10, 2013
Status800 - REGISTERED AND RENEWED
Status DateThursday, July 11, 2024
Registration Number4523481
Registration DateTuesday, April 29, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2013

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 18, 2013
Primary Code005
First Use Anywhere DateWednesday, November 13, 2013
First Use In Commerce DateWednesday, November 13, 2013

Trademark Owner History

Party NamePharmacyclics LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNorth Chicago, IL 60064
Party NamePharmacyclics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94085
Party NamePharmacyclics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94085
Party NamePharmacyclics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94085

Trademark Events

Event DateEvent Description
Saturday, July 13, 2013NEW APPLICATION ENTERED
Thursday, July 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2013PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 21, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 24, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, October 4, 2013ASSIGNED TO EXAMINER
Friday, October 4, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, February 21, 2014TEAS STATEMENT OF USE RECEIVED
Friday, February 21, 2014USE AMENDMENT FILED
Tuesday, April 29, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, August 12, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 29, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 25, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 8, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 12, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 12, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 18, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, May 11, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 11, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, May 11, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, April 29, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 12, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, July 11, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, July 11, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, July 11, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, July 11, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Related Keywords

imbruvica cancer treatment pharmaceuticals